Is the use of albumin of value in cirrhosis? The case not so in favour, or is there an alternative?

Digestive and Liver Disease

Volumn 35, Issue 9, 2003, Pages 664-667

  Burroughs, A K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Albumin; Cirrhosis; Paracentesis; Renal impairment; Renin angiotensin aldosterone system

Indexed keywords

ALBUMIN; DIURETIC AGENT; LOOP DIURETIC AGENT; PLASMA SUBSTITUTE; TERLIPRESSIN; ALBUMINOID;

ADRENERGIC SYSTEM; ARTERIAL PRESSURE; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG COST; HEMODYNAMICS; HEPATORENAL SYNDROME; HUMAN; IATROGENIC DISEASE; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; PARACENTESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK MANAGEMENT; SODIUM RETENTION; WATER RETENTION; BACTERIAL INFECTION; CIRCULATION; DRUG EFFECT; FIBROSIS; MICROBIOLOGY; NOTE; PERITONITIS;

ALBUMINS; ASCITES; BACTERIAL INFECTIONS; BLOOD CIRCULATION; DIURETICS; FIBROSIS; HEPATORENAL SYNDROME; HUMANS; PARACENTESIS; PERITONITIS;

EID: 1542498994     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00386-4     Document Type: Article

References (24)

1. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-7.
2. Jiminez W, Poo JL, Leivas A. Endothelin and systemic renal and hepatic haemodynamic disturbance in cirrhosis in ascites. In: Arroyo V, Gines P, Rodes J, Schrier RW, editors, Ascites and renal dysfunction in liver disease, Oxford: Blackwell Science; 1999, pp. 291-306.
3. Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems and renal function in cirrhotic patients admitted to hospital for the treatment of ascites. Gastroenterology 1988;99:482-7.
4. Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology 1998;27:264-72.
5. Vermeulen LC, Ratko TA, Erstad BL. The University Hospital Consortium guidelines for the use of albumin, non-protein colloids, and crystalloid solutions. Arch Intern Med 1995;155:373-9.
6. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomized controlled trials. Br Med J 1998;317:235-40.
7. Drummond G. Albumin and the Medicines Control Agency. Br Med J 1999;354:1038.
8. Horsey P. Albumin and hypovolaemia: is the Cochrane evidence to be trusted? Lancet 2002;359:70-2.
9. Chalmers I. I would not want an albumin transfusion. Br Med J 1998;317:885.
10. Gotzsche PC. Why we need a broad perspective on meta-analysis. It may be crucially important for patients. Br Med J 2000;321:585-6.
11. Gentilini P, La Villa G, Marra F, Carloni V, Melani L, Foschi M, et al. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. Hepatology 1996;25:481-90.
12. Studio Delphi sull'uso dell'albumina nei pazienti con cirrosi ed ascite Think Tank da mettere in una nota a parte via Mellerio n.3 20123 Milano. Tel.: +39-02-8646-5036; fax: +39-02-8646-5017; www.thinktank@infinito.it.
13. Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized controlled trial. J Hepatol 1999;30:639-45.
14. Vizzutti F, Romanelli RG, Casini-Raggi V, Montalto P, Pastacaldi S, Pinzani M, et al. Diuretic and natriuretic effects of long-term albumin infusion in patients with cirrhosis and ascites. A randomized controlled study. J Hepatol 2001;34(Suppl 1):17.
15. Arroyo V, Sort P, Gines P, Planas R. Treatment of ascites by paracentesis. In: Arroyo V, Gines P, Rhodes J, Schrier RW, editors, Ascites and renal dysfunction in liver disease, Oxford: Blackwell Science; 1999, pp. 463-79.
16. Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988;94:1493-502.
17. Gines A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70 and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996;111:1002-10.
18. Follow A, Llovet JM, Vavasa M, Planas R, Forns X, Francitorra A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994;20:1495-501.
19. Navasa M, Follo A, Filella X, Jimenez W, Francitorra A, Planas R, et al. Tumour necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998;27:1227-32.
20. Sort P, Vavasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;5(341):403-9.
21. Patch D, Burroughs AK. Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:1773-4.
22. International Ascites Club, Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-76.
23. Angeli P, Volpin R, Gerunda G, Craighero R, Roner P, Merenda R, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999;29:1690-7.
24. Guevara M, Gines P, Fernandez-Esparrach G, Sort P, Salmeron JM, Jimenez W, et al. Reversibility of hepatorenal syndrome by prolonged admission of ornipressin and plasma volume expansion. Hepatology 1998;27:35-41.